Roland Wandeler

Corporate Officer/Principal chez GRIFOLS, S.A.

53 ans

Health Technology

Consumer Services

Profil

Dr. Roland Wandeler is a President-Biopharma Business Unit at Grifols SA. Dr. Wandeler was previously employed as a Chief Executive Officer by Encinal Bio, Inc., a Chief Operating Officer by MorphoSys AG, and a VP, GM-US Bone Health & Cardiology Business Unit by Amgen, Inc. He received his graduate degree from Swiss Federal Institute of Technology and a doctorate degree from Swiss Federal Institute of Technology.

Postes actifs de Roland Wandeler

Sociétés	Poste	Début
GRIFOLS, S.A.	Corporate Officer/Principal	01/01/2024

Tous les postes actifs de Roland Wandeler

Anciens postes connus de Roland Wandeler

Sociétés	Poste	Fin
Encinal Bio, Inc.	Directeur Général	01/10/2023
MORPHOSYS AG	Directeur des opérations	31/12/2021
AMGEN INC.	Corporate Officer/Principal	-

Voir l'expérience en détail de Roland Wandeler

Formation de Roland Wandeler

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Roland Wandeler

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Grifols SA Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies	Health Technology
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Encinal Bio, Inc.